Dr. Malena M. Amato, MD

Dr. Amato practices at North Austin Surgery Center in Austin, Texas.

Dr. Amato's NPI, 1275611352, was assigned on November 2, 2006. Dr. Amato graduated from Georgetown University School Of Medicine in 1996. Dr. Amato's Texas license number on file is K9479.

Dr. Amato's primary practice is North Austin Surgery Center, at 12201 Renfert Way Suite 100, Austin, TX 78758. The practice phone is (412) 832-9088.

Dr. Amato's primary practice is North Austin Surgery Center in Austin, Texas. Dr. Amato is also affiliated with St. David's North Austin Medical Center. Dmand AI also links Dr. Amato to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amato practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Amato's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Amato is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Amato's licenses on file in 4 states: Texas, California, Maryland and Virginia.

Dmand AI lists conjunctivitis, eyelid inflammation and visual impairment and blindness among the conditions Dr. Amato treats.

CMS data shows 547 Medicare services from Dr. Amato across 13 procedure codes in 2024, for 191 Medicare patients. Medicare paid $73,744 for them.

CMS counts 191 Medicare patients who saw Dr. Amato in 2024. The largest group is 65 to 74, with 110 patients. 74% of them have high cholesterol, and 60% have high blood pressure. Their average risk score is 0.75, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amato's median patient age at 69, with 70% women.

In 2024, Dr. Amato wrote 723 Medicare Part D claims for 213 patients. 64% of them were for generic drugs. CMS names the drug for 655 of them, across 7 drugs with 11 or more claims each, at $7,466 in total drug cost. In 2023, CMS named 625 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Amato for performance year 2024, reported as part of a group. Dr. Amato accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Amato, published from 2003 to 2015. 2012 was the busiest year, with 2. The most frequent topics are Oculomotor Muscles, Blepharoptosis and Eyelids. Dr. Amato has published most often in Ophthalmic Plast Reconstr Surg. Dr. Amato's most frequent co-authors are Sean Matthew Blaydon, MD, Vikram David Durairaj, MD and Bita Esmaeli, MD.

CMS Open Payments shows 102 general payments to Dr. Amato from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Horizon Pharma plc paid the most, $667.

Dmand AI lists 14 awards for Dr. Amato, most recently Achievement Award in 2014.

Dr. Amato graduated from Georgetown University School Of Medicine in 1996. Dr. Amato is a member of AAO.

Dr. Amato is in network with 23 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.